\-\ Texto\\:\\ \ \(0\)\
\-\ normal\\ breast\\ exam\\ with\\ no\\ palpable\\ abnormalities\\ or\\ skin\\ changes\\.\ \(0\)\
\-\ this\\ is\\ a\\ benign\\ condition\\ requiring\\ no\\ further\\ treatment\\.\\ \\ the\\ patient\\ should\\ continue\\ routine\\ screening\\ mammography\\.\ \(0\)\
\-\ mammography\\:\\ \\ standard\\ cc\\ and\\ mlo\\ views\\ of\\ the\\ breasts\\ demonstrate\\ a\\ partially\\ circumscribed\\ and\\ partially\\ obscured\\ 3\\ cm\\ hyperdense\\ mass\\ in\\ the\\ upper\\ outer\\ quadrant\\ of\\ the\\ right\\ breast\\.\\ \\ there\\ are\\ no\\ suspicious\\ clusters\\ of\\ calcifications\\.\ \(0\)\
\-\ right\\ breast\\ ultrasound\\:\\ \\ there\\ is\\ a\\ 3\\.6\\ x\\ 1\\.0\\ x\\ 2\\.2\\ cm\\ solid\\ and\\ cystic\\ mass\\ with\\ partially\\ ill\\ defined\\ margins\\ within\\ the\\ upper\\ outer\\ quadrant\\ of\\ the\\ right\\ breast\\ along\\ the\\ 09\\:30\\ radial\\ and\\ approximately\\ 7\\ cm\\ from\\ the\\ nipple\\.\\ \\ the\\ lesion\\ has\\ internal\\ vascularity\\.\\ \\ the\\ cystic\\ portions\\ of\\ the\\ lesion\\ have\\ increased\\ through\\ transmission\\.\ \(0\)\
\-\ sclerosing\\ adenosis\ \(5\)\
\-\ infiltrating\\ ductal\\ carcinoma\ \(11\)\
\-\ infiltrating\\ lobular\\ carcinoma\ \(2\)\
\-\ tubular\\ carcinoma\ \(2\)\
\-\ ductal\\ carcinoma\\ in\\ situ\ \(4\)\
\-\ postoperative\\ scar\ \(0\)\
\-\ radial\\ scar\ \(3\)\
\-\ fat\\ necrosis\ \(11\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ infection\\ such\\ as\\ tuberculosis\\.\ \(0\)\
\-\ the\\ patient\\ has\\ no\\ family\\ history\\ of\\ breast\\ cancer\\ and\\ presented\\ for\\ annual\\ routine\\ screening\\ mammography\\.\ \(0\)\
\-\ mammography\\ can\\ not\\ readily\\ distinguish\\ sclerosing\\ adenosis\\ from\\ a\\ malignant\\ process\\.\\ \\ biopsy\\ is\\ typically\\ required\\ to\\ confirm\\ this\\ diagnosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mammography\\:\\ 0\\.10290923983951171\ \(0\)\
\-\ breast\\:\\ 0\\.08167248559146507\ \(0\)\
\-\ adenosis\\:\\ 0\\.06980390551592396\ \(0\)\
\-\ partially\\:\\ 0\\.060780989308726455\ \(0\)\
\-\ sclerosing\\:\\ 0\\.05237635552614441\ \(0\)\
\-\ carcinoma\\:\\ 0\\.050195392124681174\ \(0\)\
\-\ infiltrating\\:\\ 0\\.04809462335824726\ \(0\)\
\-\ outer\\:\\ 0\\.047034738911403556\ \(0\)\
\-\ scar\\:\\ 0\\.046205280800796965\ \(0\)\
\-\ 09\\:30\\:\\ 0\\.045676261264075126\ \(0\)\
\-\ ductal\\:\\ 0\\.041741209131445106\ \(0\)\
\-\ radial\\:\\ 0\\.04059770594834805\ \(0\)\
\-\ screening\\:\\ 0\\.03777237750184815\ \(0\)\
\-\ cm\\:\\ 0\\.03562626089870962\ \(0\)\
\-\ routine\\:\\ 0\\.035507219628497386\ \(0\)\
\-\ 3\\.6\\:\\ 0\\.03429167796181491\ \(0\)\
\-\ clusters\\:\\ 0\\.03374576855426141\ \(0\)\
\-\ quadrant\\:\\ 0\\.03116451745063269\ \(0\)\
\-\ obscured\\:\\ 0\\.03042010075025937\ \(0\)\
\-\ transmission\\:\\ 0\\.03042010075025937\ \(0\)\
\-\ readily\\:\\ 0\\.029901533607477073\ \(0\)\
\-\ x\\:\\ 0\\.029213122646087848\ \(0\)\
\-\ 2\\.2\\:\\ 0\\.029209661106831878\ \(0\)\
\-\ ill\\:\\ 0\\.02879493205152858\ \(0\)\
\-\ situ\\:\\ 0\\.02879493205152858\ \(0\)\
\-\ mlo\\:\\ 0\\.027883581448089906\ \(0\)\
\-\ 1\\.0\\:\\ 0\\.027559641774611492\ \(0\)\
\-\ breasts\\:\\ 0\\.027404963209069103\ \(0\)\
\-\ distinguish\\:\\ 0\\.026966842027576546\ \(0\)\
\-\ nipple\\:\\ 0\\.026310097438772693\ \(0\)\
\-\ postoperative\\:\\ 0\\.025727309959877927\ \(0\)\
\-\ cystic\\:\\ 0\\.025540235308308377\ \(0\)\
\-\ lobular\\:\\ 0\\.025007950141980435\ \(0\)\
\-\ requiring\\:\\ 0\\.024462040734426933\ \(0\)\
\-\ vascularity\\:\\ 0\\.024462040734426933\ \(0\)\
\-\ continue\\:\\ 0\\.02389028914287841\ \(0\)\
\-\ cc\\:\\ 0\\.02373788559258673\ \(0\)\
\-\ portions\\:\\ 0\\.023036635085489518\ \(0\)\
\-\ standard\\:\\ 0\\.022657342836664155\ \(0\)\
\-\ confirm\\:\\ 0\\.022536840960165363\ \(0\)\
\-\ annual\\:\\ 0\\.022191289796959803\ \(0\)\
\-\ hyperdense\\:\\ 0\\.022135873791173547\ \(0\)\
\-\ upper\\:\\ 0\\.021368709900193975\ \(0\)\
\-\ suspicious\\:\\ 0\\.021321440715927887\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.021091120702607505\ \(0\)\
\-\ tubular\\:\\ 0\\.020617805787642593\ \(0\)\
\-\ margins\\:\\ 0\\.020109038812620758\ \(0\)\
\-\ circumscribed\\:\\ 0\\.019679992679541833\ \(0\)\
\-\ defined\\:\\ 0\\.018655868737603692\ \(0\)\
\-\ condition\\:\\ 0\\.01851695030521687\ \(0\)\
\-\ views\\:\\ 0\\.0182498113950363\ \(0\)\
\-\ family\\:\\ 0\\.018146696605827517\ \(0\)\
\-\ lesion\\:\\ 0\\.018036841720211964\ \(0\)\
\-\ no\\:\\ 0\\.017833039392824913\ \(0\)\
\-\ solid\\:\\ 0\\.017659827215058963\ \(0\)\
\-\ necrosis\\:\\ 0\\.017477205769143547\ \(0\)\
\-\ process\\:\\ 0\\.017046971424014064\ \(0\)\
\-\ skin\\:\\ 0\\.017005849405383307\ \(0\)\
\-\ 7\\:\\ 0\\.016965051185534052\ \(0\)\
\-\ has\\:\\ 0\\.016629015238282672\ \(0\)\
\-\ calcifications\\:\\ 0\\.01646198836597281\ \(0\)\
\-\ abnormalities\\:\\ 0\\.016263029127970036\ \(0\)\
\-\ malignant\\:\\ 0\\.016003475007146637\ \(0\)\
\-\ required\\:\\ 0\\.015936401615478053\ \(0\)\
\-\ biopsy\\:\\ 0\\.015708255138014306\ \(0\)\
\-\ palpable\\:\\ 0\\.01569233700828907\ \(0\)\
\-\ typically\\:\\ 0\\.015629149064797784\ \(0\)\
\-\ benign\\:\\ 0\\.015280053715197936\ \(0\)\
\-\ internal\\:\\ 0\\.01484391643201436\ \(0\)\
\-\ along\\:\\ 0\\.014632403507038944\ \(0\)\
\-\ cancer\\:\\ 0\\.014555260437123137\ \(0\)\
\-\ should\\:\\ 0\\.014115070165226944\ \(0\)\
\-\ further\\:\\ 0\\.014080021460104964\ \(0\)\
\-\ right\\:\\ 0\\.01401500065974741\ \(0\)\
\-\ such\\:\\ 0\\.013841102538035504\ \(0\)\
\-\ approximately\\:\\ 0\\.01369853796142789\ \(0\)\
\-\ fat\\:\\ 0\\.013465866957935925\ \(0\)\
\-\ there\\:\\ 0\\.013178399548859987\ \(0\)\
\-\ ultrasound\\:\\ 0\\.013135350181379811\ \(0\)\
\-\ from\\:\\ 0\\.013123686146675776\ \(0\)\
\-\ infection\\:\\ 0\\.012870552197268431\ \(0\)\
\-\ changes\\:\\ 0\\.012689367752513267\ \(0\)\
\-\ through\\:\\ 0\\.012574906831196211\ \(0\)\
\-\ mass\\:\\ 0\\.012315658103083571\ \(0\)\
\-\ presented\\:\\ 0\\.012069210544157561\ \(0\)\
\-\ \\:\\:\\ 0\\.011712692393685649\ \(0\)\
\-\ metastatic\\:\\ 0\\.011145644578321711\ \(0\)\
\-\ increased\\:\\ 0\\.010831527366837594\ \(0\)\
\-\ 3\\:\\ 0\\.010367748843039065\ \(0\)\
\-\ demonstrate\\:\\ 0\\.010188871198616792\ \(0\)\
\-\ diagnosis\\:\\ 0\\.010166939537722384\ \(0\)\
\-\ can\\:\\ 0\\.01004260286253404\ \(0\)\
\-\ this\\:\\ 0\\.00995997112242625\ \(0\)\
\-\ exam\\:\\ 0\\.00972660072512714\ \(0\)\
\-\ have\\:\\ 0\\.009587762064067834\ \(0\)\
\-\ treatment\\:\\ 0\\.00896174590466781\ \(0\)\
\-\ patient\\:\\ 0\\.008876600320377077\ \(0\)\
\-\ is\\:\\ 0\\.008740271166601952\ \(0\)\
\-\ the\\:\\ 0\\.008595810447893832\ \(0\)\
\-\ within\\:\\ 0\\.008446276727389025\ \(0\)\
\-\ a\\:\\ 0\\.008219685011784482\ \(0\)\
\-\ disease\\:\\ 0\\.007236982078837845\ \(0\)\
\-\ normal\\:\\ 0\\.006940997174088606\ \(0\)\
\-\ as\\:\\ 0\\.006697292776653512\ \(0\)\
\-\ not\\:\\ 0\\.006398024205916764\ \(0\)\
\-\ history\\:\\ 0\\.00611510123164292\ \(0\)\
\-\ are\\:\\ 0\\.006035615919842496\ \(0\)\
\-\ or\\:\\ 0\\.005189237041262734\ \(0\)\
\-\ and\\:\\ 0\\.004663445744357991\ \(0\)\
\-\ in\\:\\ 0\\.004366810675028548\ \(0\)\
\-\ for\\:\\ 0\\.0037777624282005966\ \(0\)\
\-\ of\\:\\ 0\\.0036218798175540446\ \(0\)\
\-\ to\\:\\ 0\\.002212788126647597\ \(0\)\
\-\ \\.\\:\\ 0\\.002207225042322048\ \(0\)\
\-\ with\\:\\ 0\\.0012124785087035206\ \(0\)\
